[Indoor fungal exposure: What impact on clinical and biological status regarding Aspergillus during cystic fibrosis].

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal de Mycologie Médicale

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.mycmed.2015.03.005PMID 25910711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspergillus Sensitization or Carriage in Cystic Fibrosis Patients

  2014cited by this paper
• Indoor fungal contamination: Health risks and measurement methods in hospitals, homes and workplaces

  2014cited by this paper
• Possible application of the Environmental Relative Moldiness Index in France: a pilot study in Brittany.

  2013cited by this paper
• Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients

  2012cited by this paper
• [Fungal infections in cystic fibrosis].

  2011cited by this paper
• Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?

  2011cited by this paper
• Risk Factors for Aspergillus Colonization and Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis

  2010cited by this paper
• [Moulds in dwellings: health risks and involved species].

  2010cited by this paper
• The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.

  2010cited by this paper
• Moisissures et habitat : risques pour la santé et espèces impliquées

  2010cited by this paper
• WHO Guidelines for Indoor Air Quality: Dampness and Mould

  2009cited by this paper
• Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review.

  2009cited by this paper
• Cystic fibrosis mortality trends in France.

  2007cited by this paper
• Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients.

  2006cited by this paper
• Aspergillose pulmonaire aiguë invasive et pathologies pulmonaires chroniques

  2006cited by this paper
• Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA

  2005cited by this paper
• Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.

  2005cited by this paper
• Erratum: Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference (Clinical Infectious Diseases (2003) 37:Suppl. 3 (S225-64))

  2004cited by this paper
• Santé et qualité de l'environnement intérieur dans les bâtiments

  2004cited by this paper
• Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference.

  2003cited by this paper
• Pathophysiology and management of pulmonary infections in cystic fibrosis.

  2003cited by this paper
• Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis

  2003cited by this paper
• Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis.

  2002cited by this paper
• [Mycologic surveillance of the environment for preventive invasive aspergillosis. Proposals for standardization of the methodologies and implementation].

  2002cited by this paper
• Aspergillose bronchopulmonaire allergique chez l'enfant

  1999cited by this paper
• [Allergic bronchopulmonary aspergillosis in children].

  1999cited by this paper
• Les infections fongiques dans la mucoviscidose

  1999cited by this paper
• Tia por Microsporum canis en nios menores de treinta dias

  1985cited by this paper

• Dealing with mold infestation in hospitals and medical practices

  2025cites this paper
• How to Assess Fungal Contamination of Indoor Air in Dwellings of Patients with Cystic Fibrosis?

  2025cites this paper
• Influence of Fungal Colonization on Exacerbations in Patients with Cystic Fibrosis

  2024cites this paper
• L’espace domestique au prisme de la santé respiratoire

  2024cites this paper
• Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen – Update 2023 (AWMF-Register-Nr. 161/001)

  2024cites this paper
• AWMF mold guideline “Medical clinical diagnostics for indoor mold exposure” – Update 2023 AWMF Register No. 161/001

  2024cites this paper
• Bien respirer à la maison : l’écocitoyenneté familiale au prisme de la maladie respiratoire chronique de l’enfant

  2023cites this paper
• Biologie et diagnostic des infections à Aspergillus

  2023cites this paper
• [Allergic Broncho-Pulmonary Aspergillosis (ABPA) in cystic fibrosis: Mechanisms, diagnosis and therapeutic options].

  2021cites this paper
• Home Environmental Interventions for the Prevention or Control of Allergic and Respiratory Diseases: What Really Works.

  2017cites this paper
• Is the home environment an important factor in the occurrence of fungal events in cystic fibrosis?

  2015cites this paper
• Aspergillose bronchopulmonaire allergique (ABPA) et mucoviscidose : mécanismes, diagnostic et alternatives thérapeutiques

  year unknowncites this paper